Company intelligence / Profile preview

ChemoGenics BioPharma

North Carolina, United Stateschemogenicsbiopharma.com ↗

Ownership: Private
Development stage: Preclinical

Overview

ChemoGenics BioPharma is a U.S.-based contract research organization specializing in preclinical drug discovery services. They offer custom synthesis, medicinal chemistry, ADME studies, pharmacophore library creation, analytical chemistry, and process optimization. Their team has deep expertise across metabolic disease, oncology, and inflammation with experience targeting kinases, GPCRs, proteases, and nuclear receptors. They serve pharmaceutical companies as well as academic and government institutions globally. They do not appear to have an internal clinical pipeline; instead they support client programs.

Therapeutic areas: ImmunologyMetabolic DisordersOncology
Modalities: Small moleculePeptides
Industry: Drug Discovery Services

Beyond the preview

Go deeper on ChemoGenics BioPharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChemoGenics BioPharma.

Explore the full profile